Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Huita, Wu"'
Autor:
Huita Wu, Haonan Ji, Wenhui Yang, Min Zhang, Yifang Guo, Bangkai Li, Jiayin Wang, Rongrong Chen, Yuan Chen, Xin Wang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Precision medicine highlights the importance of incorporating molecular genetic testing into standard clinical care. Next-generation sequencing can detect cancer-specific gene mutations, and molecular-targeted drugs can be designe
Externí odkaz:
https://doaj.org/article/f3bc4e5592a24ddf88a6c25de3f25d0d
Publikováno v:
Immunology Letters. 250:15-22
Adoptive transfer of PD-1 knockout T cells mediated by CRISPR/Cas9 technology has been used in various cancers and got satisfactory treatment effectiveness. However, the effectiveness was limited due to the low proliferation ability, antigen recognit
Publikováno v:
Quantitative imaging in medicine and surgery. 12(9)
To explore the value of intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) in the early assessment of colorectal cancer liver metastases (CRLM).A total of 34 patients with pathologically confirmed unresectable CRLM were enrolled. All
Autor:
Huita Wu, Haonan Ji, Wenhui Yang, Min Zhang, Yifang Guo, Bangkai Li, Jiayin Wang, Rongrong Chen, Yuan Chen, Xin Wang
Publikováno v:
BMC cancer. 22(1)
Background Precision medicine highlights the importance of incorporating molecular genetic testing into standard clinical care. Next-generation sequencing can detect cancer-specific gene mutations, and molecular-targeted drugs can be designed to be e
Publikováno v:
Journal of Healthcare Engineering
Journal of Healthcare Engineering, Vol 2021 (2021)
Journal of Healthcare Engineering, Vol 2021 (2021)
Objective. The study was to develop and externally validate a prognostic nomogram to effectively predict the overall survival of patients with stomach cancer. Methods. Demographic and clinical variables of patients with stomach cancer in the Surveill
Autor:
Qinliang Fang, Fuqiang Wang, Chengrong Xie, Jie Lv, Fei Wang, Sheng Zhang, Yaping Xu, Zhenyu Yin, Sen Zheng, Jing Lu, Qing Bao, Huita Wu, Yuyan Lu
Publikováno v:
Cancer Management and Research. 11:4529-4540
Background: Due to the high recurrence and metastasis rate, the clinical outcomes of patients with hepatocellular carcinoma (HCC) are still unsatisfactory. Hepatitis B virus X-interacting protein (HBXIP) has been reported to play crucial roles in car
Autor:
Ping Zhan, Xiuming Zhang, Fuqiang Wang, Qinliang Fang, Sheng Zhang, Chengrong Xie, Huita Wu, Yuyan Lu, Fei Wang, Zhenyu Yin, Jing Lu
Publikováno v:
Cancer Management and Research. 11:2485-2497
Background: Hepatocellular carcinoma (HCC) is one of the most frequent cancers and the third leading cause of cancer-related deaths. It has been reported that lysosomal associated transmembrane protein LAPTM4B expression is significantly upregulated
Autor:
Huita Wu, Jing Lu, Qinliang Fang, Ping Zhan, Wenxiu Zhao, Sheng Zhang, Jie Lv, Yuyan Lu, Zhenyu Yin, Chengrong Xie, Junjiang Lu, Fuqiang Wang
Publikováno v:
Cancer letters. 469
Hepatocellular carcinoma (HCC) has emerged as one of the most common malignancies worldwide. It is associated with a high mortality rate, as evident from its increasing incidence and extremely poor prognosis. The deubiquitinating enzyme 26S proteasom
Publikováno v:
Bioscience Reports
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. Recently, ubiquitin-conjugating enzyme E2C (UBE2C) has been reported to be overexpressed in human cancers and act as a potential oncogene. However, littl
Autor:
Wujin Chen, Zhiyong He, Xi Chen, Feng Ye, Lifang Cai, Jing Zhang, Tianwen Xu, Yueming He, Dongfa Qiu, Li Lin, Qunying Lin, Jinhuo Lai, Sheng-Chi Chen, Dongyong Yang, Huita Wu, Wenbin Qiu, Jing-Hui Lin, Wenzheng Fang
Publikováno v:
Journal of Clinical Oncology. 39:9030-9030
9030 Background: Currently,EGFR-TKIs are widely accepted as the standard treatment for EGFR- mutant advanced non-small-cell lung cancer (NSCLC); however, acquired resistance is inevitable. Combination therapy is considered as a strategy to overcome t